Predictors of trastuzumab-induced cardiotoxicity among racially and ethnically diverse patients with HER2-positive breast cancer
TIC was more common among NHB compared to NHW, however, Black race was not consistently associated with TIC after adjustment for CVD risk factors. This suggests that CVD comorbidities (e.g., hypertension) that more frequently affect racial and ethnic minorities and are modifiable may explain differences in TIC incidence and recovery.
Authors
- Leila Mishalani
- J. Raikhelkar (ORCID: https://orcid.org/0000-0002-8561-7899)
- Anna Vaynrub (ORCID: https://orcid.org/0000-0002-8544-1758)
- Katherine D. Crew (ORCID: https://orcid.org/0000-0002-9637-2962)
Institutions
- Columbia University Irving Medical Center (US)
- Columbia University (US)
Publication Details
- Journal
- Cardio-Oncology
- Published
- 2024-10-12
- DOI
- https://doi.org/10.1186/s40959-024-00272-8
- Citations
- 1
- Primary Topic
- HER2/EGFR in Cancer Research
- Type
- article
- Field-Weighted Citation Impact
- 0.28
Funders
- National Institutes of Health
- National Cancer Institute